CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes.


Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
10 2020
Historique:
received: 15 01 2020
revised: 10 05 2020
accepted: 24 05 2020
pubmed: 24 7 2020
medline: 2 9 2021
entrez: 24 7 2020
Statut: ppublish

Résumé

Techniques that enable longitudinal tracking of cell fate after myocardial delivery are imperative for optimizing the efficacy of cell-based cardiac therapies. However, these approaches have been underutilized in preclinical models and clinical trials, and there is considerable demand for site-specific strategies achieving long-term expression of reporter genes compatible with safe noninvasive imaging. In this study, the rhesus sodium/iodide symporter (NIS) gene was incorporated into rhesus macaque induced pluripotent stem cells (RhiPSCs) via CRISPR/Cas9. Cardiomyocytes derived from NIS-RhiPSCs (NIS-RhiPSC-CMs) exhibited overall similar morphological and electrophysiological characteristics compared to parental control RhiPSC-CMs at baseline and with exposure to physiological levels of sodium iodide. Mice were injected intramyocardially with 2 million NIS-RhiPSC-CMs immediately following myocardial infarction, and serial positron emission tomography/computed tomography was performed with

Identifiants

pubmed: 32700830
doi: 10.1002/sctm.20-0019
pmc: PMC7519772
doi:

Substances chimiques

Symporters 0
sodium-iodide symporter 4XE5NDT4K1

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1203-1217

Informations de copyright

© 2020 The Authors. STEM CELLS Translational Medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press.

Références

Cell Stem Cell. 2008 Dec 4;3(6):587-90
pubmed: 19041774
Mol Ther Methods Clin Dev. 2014 Nov 12;1:14053
pubmed: 26052521
Curr Protoc Stem Cell Biol. 2017 May 16;41:4A.11.1-4A.11.13
pubmed: 28510330
Blood. 2004 Mar 1;103(5):1641-6
pubmed: 14604966
Mol Ther. 2012 May;20(5):1014-21
pubmed: 22434137
Nature. 2016 Oct 20;538(7625):388-391
pubmed: 27723741
J Am Coll Cardiol. 2008 Nov 11;52(20):1652-60
pubmed: 18992656
Nature. 2011 Mar 10;471(7337):225-9
pubmed: 21240260
EJNMMI Res. 2017 Dec;7(1):32
pubmed: 28378292
J Biol Chem. 1997 Oct 24;272(43):27230-8
pubmed: 9341168
Mol Ther. 2014 Apr;22(4):774-85
pubmed: 24441399
Annu Rev Physiol. 2017 Feb 10;79:261-289
pubmed: 28192058
J Nucl Med. 2017 Oct;58(10):1666-1671
pubmed: 28385795
Toxicol Sci. 2017 Jan;155(1):234-247
pubmed: 27701120
Circulation. 2011 Feb 1;123(4):425-43
pubmed: 21282520
EJNMMI Res. 2017 Oct 27;7(1):90
pubmed: 29080017
Stem Cells Transl Med. 2020 Oct;9(10):1203-1217
pubmed: 32700830
N Engl J Med. 2010 Oct 7;363(15):1397-409
pubmed: 20660394
J Nucl Med. 2006 Nov;47(11):1851-7
pubmed: 17079819
Biochim Biophys Acta. 1993 Jun 8;1154(1):65-82
pubmed: 8507647
Mol Ther. 2016 Apr;24(4):678-84
pubmed: 26867951
Nat Rev Cancer. 2011 Dec 01;12(1):51-8
pubmed: 22129804
Circulation. 2012 Jul 24;126(4):430-9
pubmed: 22767659
Nucl Med Biol. 2015 Jul;42(7):621-9
pubmed: 25899941
Nat Methods. 2014 Aug;11(8):855-60
pubmed: 24930130
Toxicol Sci. 2016 Dec;154(2):320-331
pubmed: 27621282
Stem Cells. 2013 May;31(5):829-37
pubmed: 23355363
J Am Coll Cardiol. 2014 Aug 5;64(5):436-48
pubmed: 25082575
Clin Nucl Med. 2018 Mar;43(3):162-167
pubmed: 29356744
J Am Coll Cardiol. 2016 May 10;67(18):2161-2176
pubmed: 27151349
Sci Rep. 2018 Apr 12;8(1):5907
pubmed: 29651156
Mol Ther. 2017 Jan 4;25(1):44-53
pubmed: 28129126
Circ Arrhythm Electrophysiol. 2017 Jun;10(6):
pubmed: 28630169
Stem Cell Reports. 2018 Feb 13;10(2):422-435
pubmed: 29398480
Cell Rep. 2014 May 22;7(4):1298-1309
pubmed: 24835994
Anal Bioanal Chem. 1996 Mar;354(5-6):576-9
pubmed: 15067448
Curr Protoc Stem Cell Biol. 2017 Nov 15;43:5A.11.1-5A.11.14
pubmed: 29140568
Nat Biotechnol. 2018 Aug;36(7):597-605
pubmed: 29969440
J Nucl Med. 2016 Sep;57(9):1454-9
pubmed: 27103021
Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2108-16
pubmed: 20577737
Circ Res. 2012 Oct 12;111(9):1125-36
pubmed: 22912385
Nature. 2014 Jun 12;510(7504):273-7
pubmed: 24776797

Auteurs

John W Ostrominski (JW)

Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Ravi Chandra Yada (RC)

Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Noriko Sato (N)

Molecular Imaging Program, Laboratory of Cellular Therapeutics, National Cancer Institute (NCI), NIH, Bethesda, Maryland, USA.

Michael Klein (M)

Division of Cardiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.

Ksenia Blinova (K)

Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA.

Dakshesh Patel (D)

Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA.

Racquel Valadez (R)

Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.

Maryknoll Palisoc (M)

Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.

Stefania Pittaluga (S)

Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.

Kah-Whye Peng (KW)

Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Hong San (H)

Animal Surgery and Resources Core, NHLBI, NIH, Bethesda, Maryland, USA.

Yongshun Lin (Y)

iPSC Core, NHLBI, NIH, Bethesda, Maryland, USA.

Falguni Basuli (F)

Chemistry and Synthesis Center, NHLBI, NIH, Bethesda, Maryland, USA.

Xiang Zhang (X)

Chemistry and Synthesis Center, NHLBI, NIH, Bethesda, Maryland, USA.

Rolf E Swenson (RE)

Chemistry and Synthesis Center, NHLBI, NIH, Bethesda, Maryland, USA.

Mark Haigney (M)

Division of Cardiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.

Peter L Choyke (PL)

Molecular Imaging Program, Laboratory of Cellular Therapeutics, National Cancer Institute (NCI), NIH, Bethesda, Maryland, USA.

Jizhong Zou (J)

iPSC Core, NHLBI, NIH, Bethesda, Maryland, USA.

Manfred Boehm (M)

Laboratory of Cardiovascular Regenerative Medicine, NHLBI, NIH, Bethesda, Maryland, USA.

So Gun Hong (SG)

Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Cynthia E Dunbar (CE)

Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH